MENU

Dymax to Showcase Advanced UV/LED Curing Adhesives for Battery & Electronics Manufacturing, Expand HLC Medical Portfolio at The Battery Show Europe 2026

Dymax USA
Overview
Dymax will unveil its latest UV/LED-curable adhesives and protective solutions tailored for battery and electronics manufacturing, alongside an expanded portfolio of low-viscosity HLC medical adhesives, at The Battery Show Europe 2026. These rapid-curing materials offer high-efficiency bonding and sealing, significantly enhancing productivity and reducing energy consumption in critical applications. The expansion into advanced medical-grade products further solidifies Dymax’s position in high-growth, high-reliability markets.
In Depth

Key Findings

Dymax announced its participation in The Battery Show Europe 2026, where it will feature its newest UV and LED-curable adhesives and protective solutions specifically engineered for battery and electronics manufacturing. Concurrently, the company will highlight the expansion of its High-Level Chemistry (HLC) adhesive portfolio for medical devices, including new low-viscosity offerings.

Technical & Clinical Details

  • UV/LED-Curable Adhesives: These advanced light-curable materials are designed to address critical bonding and protection challenges in battery assembly, such as cell-to-cell bonding, thermal management, and sealing of electronic components. Their rapid cure times, often measured in seconds, allow for significant throughput increases and reduced energy consumption compared to traditional thermal cure methods. This is particularly advantageous for high-volume electric vehicle (EV) battery production, where speed and reliability are paramount.
  • Expanded HLC Medical Adhesives: The enhanced HLC product line, now featuring lower viscosity options, is formulated for complex, miniaturized medical devices including wearables, diagnostic equipment, and surgical tools. These medical-grade adhesives meet stringent biocompatibility requirements (e.g., ISO 10993-10/-23 for sensitization and irritation, and ISO 10993-5 for cytotoxicity) and provide robust, reliable bonds for skin-contact applications and sensitive internal components, ensuring patient safety and device integrity.

Background & Context

The demand for high-performance adhesives is surging across several high-tech sectors. In the automotive industry, the transition to EVs necessitates advanced materials for battery construction that can withstand harsh operating conditions and optimize thermal management. Simultaneously, the proliferation of smart electronics, driven by 5G and AI, requires adhesives capable of precise bonding in densely packed, heat-sensitive environments. The medical device market continues to innovate with smaller, more sophisticated wearables that demand biocompatible, flexible, and durable bonding solutions.

Strategic Significance & Outlook

This showcase underscores Dymax’s commitment to delivering cutting-edge adhesive solutions that cater to the evolving needs of high-growth industries. The company’s focus on UV/LED curing technology positions it at the forefront of sustainable manufacturing, offering efficiency gains and a reduced environmental footprint. The strategic expansion of its medical portfolio also reflects a clear alignment with trends favoring minimally invasive and wearable health technologies, promising continued market relevance and growth.

Source: https://dymax.cc/news-and-media.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Let's share this post !

Author of this article

Comments

To comment

TOC